BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1373456)

  • 1. [Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas].
    Morita T; Kondo S
    Nihon Hinyokika Gakkai Zasshi; 1992 Mar; 83(3):334-7. PubMed ID: 1373456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative analyses of human prostatic alpha-adrenoceptors and effects of terazosin on the alpha-adrenoceptor activity].
    Morita T
    J Smooth Muscle Res; 1991 Jun; 27(3):149-54. PubMed ID: 1726720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]bunazosin, a novel selective radioligand of alpha 1 adrenoceptors in human prostates.
    Yamada S; Suzuki M; Matsuoka Y; Kato Y; Kimura R; Maruyama M; Kawabe K
    J Urol; 1991 Sep; 146(3):877-80. PubMed ID: 1714973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding characteristics of naftopidil and alpha 1-adrenoceptor antagonists to prostatic alpha-adrenoceptors in benign prostatic hypertrophy.
    Yamada S; Suzuki M; Kato Y; Kimura R; Mori R; Matsumoto K; Maruyama M; Kawabe K
    Life Sci; 1992; 50(2):127-35. PubMed ID: 1370569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia.
    Lepor H; Gup DI; Baumann M; Shapiro E
    Urology; 1988 Dec; 32(6 Suppl):21-6. PubMed ID: 2462301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
    Tsuchihashi H; Nagatomo T
    J Pharmacobiodyn; 1989 Mar; 12(3):170-4. PubMed ID: 2569512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative analyses of alpha-adrenoceptors in human prostatic capsule, adenoma and urethra--a comparison between normal prostate and hypertrophied prostate].
    Morita T; Kondo S
    Nihon Hinyokika Gakkai Zasshi; 1992 Mar; 83(3):328-33. PubMed ID: 1373455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain.
    Lepor H; Baumann M; Shapiro E
    J Urol; 1988 Sep; 140(3):664-7. PubMed ID: 2457715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract.
    Lefèvre-Borg F; O'Connor SE; Schoemaker H; Hicks PE; Lechaire J; Gautier E; Pierre F; Pimoule C; Manoury P; Langer SZ
    Br J Pharmacol; 1993 Aug; 109(4):1282-9. PubMed ID: 8104650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.
    Hanft G; Gross G
    Br J Pharmacol; 1989 Jul; 97(3):691-700. PubMed ID: 2569345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha-adrenergic blocking effect of prazosin on the human prostate.
    Shapiro A; Mazouz B; Caine M
    Urol Res; 1981; 9(1):17-20. PubMed ID: 6115493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Density and localization of alpha 1-adrenoceptors in hypertrophied prostate.
    Kawabe K; Moriyama N; Hamada K; Ishima T
    J Urol; 1990 Mar; 143(3):592-5. PubMed ID: 1689399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characterization and localization of alpha 1-adrenoceptors in human prostate--with special reference to the zonal difference in receptor distribution].
    Kobayashi S
    Nihon Hinyokika Gakkai Zasshi; 1991 Aug; 82(8):1241-9. PubMed ID: 1717729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia.
    Lepor H; Shapiro E
    J Urol; 1984 Dec; 132(6):1226-9. PubMed ID: 6209426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics of alpha 1-adrenoceptors in bovine prostate using a radioligand binding assay.
    Maruyama K; Kinami J; Tsuchihashi H; Nagatomo T
    J Pharmacobiodyn; 1991 Jun; 14(6):315-9. PubMed ID: 1686059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy.
    Yamada S; Ashizawa N; Ushijima H; Nakayama K; Hayashi E; Honda K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):326-30. PubMed ID: 2441028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK; Blaylock NA; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.
    Laporte AM; Schechter LE; Bolaños FJ; Vergé D; Hamon M; Gozlan H
    Eur J Pharmacol; 1991 May; 198(1):59-67. PubMed ID: 1680714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.
    Wilde MI; Fitton A; McTavish D
    Drugs; 1993 Mar; 45(3):410-29. PubMed ID: 7682910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of bunazosin-sensitive alpha1-adrenoceptors in human renal medulla.
    Yasuda G; Umemura S; Ishii M
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):163-8. PubMed ID: 9269942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.